$5.85
2.27% day before yesterday
Nasdaq, Dec 27, 10:00 pm CET
ISIN
US62459M1071
Symbol
MOVE

Movano Inc Stock price

$5.85
+0.46 8.53% 1M
+1.58 36.84% 6M
-5.87 50.09% YTD
-3.90 40.00% 1Y
-37.50 86.51% 3Y
-93.15 94.09% 5Y
-93.15 94.09% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
+0.13 2.27%
ISIN
US62459M1071
Symbol
MOVE

Key metrics

Market capitalization $38.81m
Enterprise Value $27.66m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 30.73
P/S ratio (TTM) P/S ratio 43.12
P/B ratio (TTM) P/B ratio 3.79
Revenue (TTM) Revenue $900.00k
EBIT (operating result TTM) EBIT $-25.55m
Free Cash Flow (TTM) Free Cash Flow $-23.24m
Cash position $11.27m
EPS (TTM) EPS $-5.20
P/E forward negative
P/S forward 16.16
EV/Sales forward 11.52
Short interest 2.10%
Show more

Is Movano Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Movano Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Movano Inc:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Movano Inc:

Buy
100%

Financial data from Movano Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
0.90 0.90
-
100%
- Direct Costs 2.48 2.48
1,553% 1,553%
276%
-1.58 -1.58
953% 953%
-176%
- Selling and Administrative Expenses 11 11
9% 9%
1,272%
- Research and Development Expense 12 12
34% 34%
1,377%
-25 -25
19% 19%
-2,823%
- Depreciation and Amortization 0.14 0.14
7% 7%
16%
EBIT (Operating Income) EBIT -26 -26
19% 19%
-2,839%
Net Profit -25 -25
20% 20%
-2,786%

In millions USD.

Don't miss a Thing! We will send you all news about Movano Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Movano Inc Stock News

Neutral
PRNewsWire
27 days ago
Company's first 510(k) clearance unlocks a TAM of $40 billion in healthcare B2B opportunities PLEASANTON, Calif. , Dec. 2, 2024 /PRNewswire/ -- Movano Health  (Nasdaq: MOVE), a pioneer in health technology, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the pulse oximeter in its EvieMED Ring.
Neutral
Seeking Alpha
about one month ago
Movano Inc. (NASDAQ:MOVE ) Q3 2024 Earnings Conference Call November 14, 2024 5:00 PM ET Company Participants J. Cogan - CFO John Mastrototaro - CEO Tyla Bucher - Chief Marketing Officer Michael Soule - Chief Commercial Officer Conference Call Participants Bruce Jackson - The Benchmark Company Operator Ladies and gentlemen, greetings, and welcome to the Movano Health Third Quarter Earnings Conf...
Neutral
PRNewsWire
about one month ago
Highlights successful Evie Ring back-in-stock execution Updates status of EvieMED 510(k) application review Focuses on launch of EvieMED and securing B2B opportunities Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif. , Nov. 14, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported third quarter 2024 results and provided a business update.
More Movano Inc News

Company Profile

Movano, Inc. is a health-focused technology company. The firm uses non-invasive technology to enable individuals and their healthcare partners to measure and manage their health conditions. It offers solutions through the app, the cloud, the wearable, and the sensor. The company was founded by Michael Leabman in January 2018 and is headquartered in Pleasanton, CA.

Head office United States
CEO John Mastrototaro
Employees 30
Founded 2018
Website www.movano.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today